Pharmaceutical Gelatin Market Size to Reach USD 2.79 Billion by 2032 | CAGR 5.77% (2024-2032)
The Pharmaceutical Gelatin Market was valued at USD 1.69 billion in 2023 and is projected to reach USD 2.79 billion by 2032, growing at a CAGR of 5.77% from 2024 to 2032. Market growth is driven by increasing demand for gelatin in capsules, soft gels, and drug delivery systems amid rising pharmaceutical R&D investments and prescription medication spending. Additionally, expanding food, cosmetics, pharmaceutical, and nutraceutical industries contribute to gelatine consumption. However, growth is challenged by rising popularity of plant-based and synthetic alternatives like HPMC and pullulan, especially among vegan and allergy-conscious consumers. The market outlook remains positive due to gelatine\'s biocompatibility and wide applications across healthcare and wellness sectors.